Sativex Archives

Cannabis medicine improved MS symptom in small study

Cannabis medicine improved MS symptom in small studyPublished: 24 October 2022 People with multiple sclerosis (MS) who were treated with nabiximols – which contains compounds of the cannabis plant and is licenced in the UK under the brand name Sativex – saw their spasticity reduced and had improved arm and

74% of MS patients found this treatment eased spasticity

74% of MS patients found this treatment eased spasticity Published: 09 July 2021 Medical cannabis treatment Sativex has been found to be effective as an add-on therapy for easing spasticity in multiple sclerosis (MS) in people who had not responded to other anti-spastic medication. The real-world study, which took place

Spasticity scale test not enough to show Sativex benefits

Spasticity scale test not enough to show Sativex benefits Published: 26 May 2020 A new study from Italy has found that Sativex, a type of medical cannabis licensed in the UK for some symptoms of multiple sclerosis MS, eases symptoms related to spasticity, even in those with no significant improvements

Cannabis medicine improved MS symptom in small study

74% of MS patients found this treatment eased spasticity

Spasticity scale test not enough to show Sativex benefits

Get started

Ways to pay

Fundraise for us

My Portal

© ms-uk.org all rights reserved